Analyst Ratings for Ironwood Pharmaceuticals (IRWD)

IRWD Rating Summary

IRWD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on IRWD
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $13.50 (+5.1%) * Over Last 12-Mos
Rating Score: 3.5 / 10   Percentile Rank: 31%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/30/2020 Wells Fargo David Maris Downgrade Equal Weight
(Overweight)
9.00
(N/A)
9.53
(12.85)
34.84% Details
6/17/2020 Northland Capital Markets
» Updated 5/18/2021
Tim Chiang New Coverage Outperform
(N/A)
15.00
(13.00)
9.53
(12.85)
34.84% Details
Like IRWD Ratings? Also take a look at VRTX, GBIO, ACIU, CYCN

IRWD Ratings News